Obesity Reduces Effectiveness of Febuxostat in Gout Treatment, Study Finds Medha Baranwal16 Feb 2025 9:45 PM ISTChina: A recent prospective cohort study has revealed that obesity significantly reduces the effectiveness of febuxostat-based urate-lowering therapy...
Colchicine prophylaxis in urate-lowering therapy may reduce risk of cardiovascular events: Study Jacinthlyn Sylvia27 Dec 2024 8:45 PM ISTA new study published in the journal of The Lancet Rheumatology showed that individuals with gout who started urate-lowering treatment had a decreased...
Among gout patients, Flare Risk similar during initiation and titration of Allopurinol and Febuxostat: Study Dr Riya Dave12 July 2024 7:00 AM ISTResearchers in a recent study have found that the risk of gout flares is similar during the initiation and titration of allopurinol and febuxostat...
Gout patients with negative dual-energy CTs generally have milder illness and lower comorbidities: Study Aditi6 March 2024 11:15 PM ISTDual-energy computed tomography (DECT) is used in the imaging of gouty arthritis. It has become increasingly widely used in recent years. DECT is a...
Control of Anthropometric Measures and Lipids may improve Gout Outcomes Dr Riya Dave18 Dec 2023 6:00 PM ISTA recent study, published in Rheumatic and Musculoskeletal Diseases, delved into the nuanced relationship between gout outcomes, lifestyle changes,...
Clinical practice guidelines on gout management disagree on when to initiate urate-lowering therapy Dr. Kamal Kant Kohli27 Aug 2023 8:00 PM ISTAustralia: A recent article published in BMC Rheumatology has shed light on the core recommendations for gout management in first-line and specialist...
Allopurinol fails to improve CV outcomes in ischemic heart disease patients: ALL-HEART trial Dr.Niharika Harsha B12 Oct 2022 8:30 PM ISTA recent study found that allopurinol did not improve the primary outcomes in cardiovascular patients aged 60 years or older with ischemic heart...
Allopurinol non-inferior to febuxostat for gout treatment: Study Medha Baranwal3 Dec 2021 9:00 AM ISTUSA: Allopurinol, when dosed appropriately as part of a treat-to-target strategy, is non-inferior to febuxostat for gout treatment, according to...
Urate-lowering therapy with allopurinol does not lower systolic BP, Finds study Dr. Nandita Mohan25 Jun 2021 9:15 AM ISTAccording to a recent research, it has been observed that urate-lowering therapy with allopurinol does not lower systolic BP or hsCRP level in ...
Urate-lowering therapy may not improve kidney and cardiovascular outcomes Dr Kartikeya Kohli20 Oct 2020 8:35 PM ISTUrate-lowering therapy did not produce benefits on the clinical outcomes, including major adverse cardiovascular events, all-cause mortality, and...
Ultrasound detects significantly low crystal deposition in gout by ULT: Study Medha Baranwal31 Aug 2020 11:28 AM ISTNorway: A treat-to-target approach with urate lowering therapy caused a significant reduction of ultrasound-detected crystal depositions...
New 2020 Gout management guidelines by ACR Hina Zahid14 May 2020 3:45 PM ISTATLANTA – American College of Rheumatology (ACR) has released the 2020 Guideline for the Management of The guidelines have been published in the...
